KELER TIBOR 4
4 · Celldex Therapeutics, Inc. · Filed Jun 19, 2020
Insider Transaction Report
Form 4
KELER TIBOR
Sr. VP & CSO
Transactions
- Award
Incentive Stock Option (right to buy)
2020-06-18+108,000→ 108,000 totalExercise: $10.38From: 2021-06-18Exp: 2030-06-18→ Common Stock (108,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
- [F2]25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.